John Williford

John Williford

Elizabeth Jordan Dreskin

Elizabeth Jordan Dreskin

Vanitha Margan, Global Product Manager, Bio-Plex Immunoassays, Bio-Rad

Vanitha Margan

Presented by:

John Williford, Director of Biomanufacturing and Contract Research, Nortis

Elizabeth Jordan Dreskin, R&D Manager, Bio-Rad Laboratories, Inc.

Vanitha Margan, Global Product Manager, Bio-Rad Laboratories, Inc.

Available on Demand

Join our webinar to explore the cutting-edge field of 3D cell culture models and their application in the development of therapeutics. Discover how researchers are utilizing xMAP Multiplex Immunoassays to monitor biomarkers associated with tubular nephrotoxicity in kidney proximal tubule chips. Learn how this approach saves time and precious samples compared with conventional methods by enabling the analysis of multiple targets within a single well. Don’t miss this opportunity to delve into the world of 3D cell culture and learn how these model systems will help streamline drug efficacy and safety studies.

Watch Webinar
Previous post

Mastering MIQE: How to Publish High-Quality qPCR Data

Next post

mAb Purification Process Development Using Mixed-Mode Resins — The DOE Approach